Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P van Meerbeeck

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Journal of Biomedical Optics|December 1, 2004
Raman microspectroscopic mapping studies of human bronchial tissueSenada Koljenović, Tom C Bakker Schut, Jan P van Meerbeeck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort studyKevin Hollevoet, Joris Van Cleemput, Joël Thimpont, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experienceRobert C Rintoul, Kurt G Tournoy, Hesham El Daly, et al.
Clinical Chemistry|May 2, 2009
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serumKevin Hollevoet, Dirk Bernard, Frank De Geeter, et al.
ERJ Open Research|February 18, 2026
Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysisKathleen Zwijsen, Reinier R L Wener, Ellen Heirwegh, et al.
Tobacco Prevention & Cessation|March 2, 2022
Lung cancer in Europe: The way forwardMonica Racovita, Eleanor Wheeler, Suzanne Wait, et al.
Chest|July 9, 2011
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factorKevin Hollevoet, Kristiaan Nackaerts, Olivier Thas, et al.
Clinical Lung Cancer|January 13, 2019
Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter StudyAnnelies Janssens, Sofia Derijcke, Daniëlle Galdermans, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopyKurt G Tournoy, Robert C Rintoul, Jan P van Meerbeeck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinomaMark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Journal of Biomedical Optics|December 1, 2004
Raman microspectroscopic mapping studies of human bronchial tissueSenada Koljenović, Tom C Bakker Schut, Jan P van Meerbeeck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort studyKevin Hollevoet, Joris Van Cleemput, Joël Thimpont, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experienceRobert C Rintoul, Kurt G Tournoy, Hesham El Daly, et al.
Clinical Chemistry|May 2, 2009
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serumKevin Hollevoet, Dirk Bernard, Frank De Geeter, et al.
ERJ Open Research|February 18, 2026
Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysisKathleen Zwijsen, Reinier R L Wener, Ellen Heirwegh, et al.
Tobacco Prevention & Cessation|March 2, 2022
Lung cancer in Europe: The way forwardMonica Racovita, Eleanor Wheeler, Suzanne Wait, et al.
Chest|July 9, 2011
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factorKevin Hollevoet, Kristiaan Nackaerts, Olivier Thas, et al.
Clinical Lung Cancer|January 13, 2019
Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter StudyAnnelies Janssens, Sofia Derijcke, Daniëlle Galdermans, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopyKurt G Tournoy, Robert C Rintoul, Jan P van Meerbeeck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinomaMark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Pageof 19